TP53 and hepatocellular carcinoma: By grouping studies according to the publication year, geographic location, sample size, different IHC antibodies, mutational analysis methods, or prevalence of p53 alterations, subgroup analysis revealed that the diagnostic accuracy of IHC-determined p53 overexpression in identifying p53 mutations in HCC remained consistent (Table 2).